Curanex Pharmaceuticals Announces 1-for-20 Reverse Stock Split

What Happened

• Curanex Pharmaceuticals Inc. (CURX) announced a 1-for-20 reverse stock split of its common stock, approved by the Board on July 22, 2026. The company filed a Certificate of Amendment with the Nevada Secretary of State on August 14, 2026, which becomes effective at 12:01 a.m. PT on August 20, 2026. The Common Stock is expected to trade on Nasdaq on a reverse split–adjusted basis under the existing ticker “CURX” when markets open on August 20, 2026 (with a new CUSIP).
• The reverse split was implemented under prior board and stockholder consents that authorized a split ratio between 1-for-10 and 1-for-50; the Board selected 1-for-20.

Key Details

• Shares: Every 20 pre-split shares will convert into 1 post-split share; based on 31,364,812 pre-split shares, post-split outstanding is expected to be roughly 1,568,241 shares (subject to adjustments).
• Nasdaq compliance: The reverse split is intended to regain compliance with Nasdaq’s $1.00 minimum bid price requirement (Rule 5550(a)(2)).
• Equity awards & capitalization: Proportionate adjustments will be made to outstanding equity awards under the Company’s 2026 Equity Incentive Plan and to exercise/grant prices. Authorized common shares (475,000,000) and preferred shares (25,000,000) and the par value ($0.0001) remain unchanged.
• Fractional shares: No fractional shares will be issued; fractional entitlements will be rounded up to the nearest whole share (no cash paid). VStock Transfer, LLC is acting as exchange agent and will provide instructions to record holders.

Why It Matters

• For investors, the reverse split changes share count and per‑share price but does not change the company’s overall market value or authorized share limits. The main purpose is procedural: to meet Nasdaq’s $1.00 minimum bid price and maintain the company’s Nasdaq listing. Holders should expect their share totals to be reduced by a 20:1 ratio (with rounding rules applied) and see post-split trading starting Aug 20, 2026.